分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Development of in situ refolding technology for directed evolution of enzymes from eukaryotes

Tang Zhengyu, Huang Xiao, Wen Jiahong, Sun Huiwan, Ping Xianqing, Zhao Xiuyun, Qi Gaofu

Journal:3 Biotech

IF:3.1

DOI:10.1007/s13205-026-04693-3

PMID:

Published:2026-01-27

research field:肿瘤学药理学癌症生物学神经生物学分子医学

Abstract

This study establishes an in situ refolding–based high-throughput screening strategy that enables directed evolution of eukaryotic enzymes expressed as inactive inclusion bodies in Escherichia coli. Guided by bioinformatic analysis, the catalytic domain of human DNase I was selected for mutagenesis, generating a library of 1,051 variants. A streamlined workflow—comprising microplate-based cultivation, induction, cell lysis, in situ denaturation with alkaline buffer containing β-mercaptoethanol, refolding with arginine, and activity detection—allowed efficient screening directly from insoluble expression. From this library, a DNase I mutant carrying N78T and V90N substitutions exhibited a 4.1-fold increase in enzymatic activity compared with the wild type. The same strategy applied to benzonase yielded a mutant with a 40% activity improvement, demonstrating the method’s generality. Collectively, these results show that in situ refolding enables rapid identification of functional mutants from eukaryotic proteins produced as inclusion bodies, thereby improving the efficiency of directed evolution for otherwise challenging enzyme targets.

本文使用的Yeasen产品

购物车
客服
转染试用